Name: Cagrilintide
Brand: Lilipeptide
SKU: LILI-cagrilintide
Availability: OutOfStock

Cagrilintide at a glance

Amylin is a peptide hormone secreted by pancreatic beta cells alongside insulin. Cagrilintide, developed by Novo Nordisk under the code AM833, is an engineered amylin analogue carrying a fatty-acid side chain that associates reversibly with albumin, slowing its removal from the circulation. Further sequence changes were introduced to reduce the tendency of native human amylin to aggregate into fibrils. Its listed molecular formula is C194H312N54O59S2, giving a molecular weight of about 4409 g/mol.

Price and availability

Lilipeptide lists this listing, shipped from China. It is listed at $142.00. Your payment waits in escrow until you confirm the parcel arrived, and only then is it released to the brand.

This listing: Lilipeptide Cagrilintide

Brand: Lilipeptide
Other strengths: Cagrilintide 5mg + Semaglutide 5mg $257.00
Also sold by: Lab77 Peptides 10mg $119.00 · HK Peptide 10mg $150.00 · TFC Peptides 10mg $125.00 · Sulan Bio 10mg $173.40 · Lianhua Peptide Co. 10mg $173.40 · Kensington Biosciences 10mg $420.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

What it is studied for

Amylin receptors are unusual: each forms when the calcitonin receptor pairs with one of the receptor activity-modifying proteins, RAMP1, RAMP2 or RAMP3. Cagrilintide is described as a nonselective agonist that activates these amylin receptor complexes and the calcitonin receptor itself. In animal and early human studies, signaling through hindbrain regions such as the area postrema has been linked to delayed gastric emptying, reduced food intake and lower post-meal glucagon. Because these pathways differ from GLP-1 receptor signaling, investigators examine the two classes side by side to separate their contributions to energy-balance endpoints.

Research and regulatory status

Clinical development has centered on the fixed combination with semaglutide, often called CagriSema, which has been evaluated in large late-stage obesity and type 2 diabetes trials. Cagrilintide on its own has been studied in a mid-stage weight-management trial. As of early 2026, neither the single agent nor the combination should be described as an approved medicine, and its regulatory position can change quickly, so readers should confirm it against current agency records. Mechanistic detail still relies heavily on rodent pharmacology.

Checking the lab data

Because cagrilintide is a large lipidated peptide, a convincing report pairs HPLC purity with high-resolution mass spectrometry showing a deconvoluted mass close to 4409 Da, which confirms the fatty-acid side chain is present. A missing or truncated lipid would show up as a lower mass. Peptide-content figures help when comparing listings per mg. Expect a white lyophilized cake; solutions prepared for analysis should be clear, and turbidity or gel-like residue suggests aggregation.

No independent report is attached to this listing yet. You can compare brands that publish one on the Cagrilintide page or browse the lab reports directory.

Listing details

Compound: Cagrilintide
Synonyms: CAGRI, AM833
Class: Long-acting amylin receptor agonist
Format: Lyophilized (freeze-dried) powder
Molecular formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular weight: 4409.0 g/mol
Sold by: Lilipeptide
Ships from: China
Lab report: Not yet published

Storage and preparation

Freeze-dried peptide keeps best sealed, cold and dark. Once it has been dissolved, refrigerate it, avoid repeated warming and follow the stability limits in your study protocol.

Buyer questions

What does the code AM833 refer to?

AM833 is the development code under which cagrilintide appeared in early clinical publications and trial registrations. Papers and registries may use either name, so searching both terms gives a more complete view of the literature. The code and the nonproprietary name describe the same molecule, not two related compounds.

Why did researchers engineer around native amylin's stability problems?

Human amylin readily clumps into insoluble fibrils, which complicates formulation and laboratory handling. An earlier analogue, pramlintide, addressed this with proline substitutions. Cagrilintide's design added further sequence changes plus a lipid chain, aiming for a molecule that stays soluble and persists in circulation far longer than the native hormone.

What if the parcel never arrives?

Open a claim from your order page. The payment is still in escrow at that point, so a claim decided in your favour is refunded to your Escrow Wallet.

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.